Skip to main content
U.S. flag

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Find more clinical trials

Early-Onset Alzheimer's Disease Genomic Study

Start: June 16, 2017
End: June 2022
Enrollment: 50

What Is This Study About?

This study will collect samples from people with early-onset Alzheimer's disease and their immediate family members to better understand how changes in the body are related to development of the disease. Participants will be asked to complete a one-time blood draw. Researchers will analyze the samples to identify biomarkers (biological measures of the disease) that could be used to help doctors diagnose, treat, and monitor people at risk of developing early-onset Alzheimer's.

Do I Qualify To Participate in This Study?

Minimum Age: 40 Years

Maximum Age: 65 Years

Must have:

  • Diagnosis of early-onset Alzheimer's disease
  • Parents and siblings of the person with Alzheimer's disease

Must NOT have:

  • Family history of early- or late-onset Alzheimer's disease
  • Uncontrolled illness, including psychiatric illness, or situations that would limit ability to meet study requirements or give written or verbal informed consent

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

Study Contact
Sarah B Burris, MHA

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Texas
Baylor Scott & White AT&T Memory Center
Dallas, TX 75231
Recruiting
Sarah B Burris, MHA

Who Sponsors This Study?

Lead: Baylor Research Institute

Collaborator Sponsor

  • Translational Genomics Research Institute

Source: ClinicalTrials.gov ID: NCT03645993

alzheimers.gov

An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health